Topic: PHARMACEUTICAL
673 results were found.
Afton Scientific to expand biopharmaceutical facility in Albemarle County, create hundreds of jobs - October 11, 2024
Japan's Kobayashi Pharmaceutical factory inspected amid supplement health scare - March 30, 2024
Latvia exports 90 pct of pharmaceutical products in 2023 - March 27, 2024
Fennec Pharmaceuticals and Norgine to commercialize PEDMARQSI in Europe, Australia, and New Zealand - March 20, 2024
Irish exports jump 22% as pharmaceuticals rebound - March 18, 2024
54 people sickened at pharmaceutical packaging site in Pennsylvania - February 24, 2024
BioMarin Pharmaceutical Q4 revenues $646.2 million - February 24, 2024
California AG announces $150 million multistate agreement with Hikma Pharmaceuticals for its role in opioid epidemic - February 6, 2024
Impel Pharmaceuticals files for Chapter 11 in Texas and signs "stalking horse" deal to facilitate sale - December 21, 2023
Amylyx Pharmaceuticals appoints Camille L. Bedrosian as chief medical officer - November 29, 2023
Boehringer Ingelheim to acquire T3 Pharmaceuticals in deal worth over $500m - November 24, 2023
Poland imposed fine of more than $1.1m on Natural Pharmaceuticals - October 23, 2023
Otsuka Pharmaceutical to acquire Mindset Pharma - September 1, 2023
LEO Pharma to acquire Timber Pharmaceuticals - August 24, 2023
Regeneron Pharmaceuticals to acquire Decibel Therapeutics in $109 million deal - August 10, 2023
Massive tornado destroys Pfizer pharmaceutical plant - July 21, 2023
TFF Pharmaceuticals awarded $2.97 million to develop universal influenza vaccine - June 27, 2023
Dechra Pharmaceuticals agreed £4.46bn bid from Swedish private equity firm EQT - June 2, 2023
Oncomatryx acquires Tube Pharmaceuticals - May 19, 2023
Corbus Pharmaceuticals Q1 loss $17.7 million - May 10, 2023
Full-Life to establish GMP manufacturing facility for radiopharmaceutical drug production in Belgium - May 4, 2023
EU chemical and pharmaceutical trade recorded robust growth - April 27, 2023
EQT offers £4.6bn for Dechra Pharmaceuticals - April 14, 2023
Generic pharmaceuticals market expected to reach $682.9 billion - March 21, 2023
Vanda Pharmaceuticals appoints Tage Honoré to board - March 17, 2023
CDC concludes Maiden Pharmaceuticals cough syrups likely to blame for children's deaths in Gambia - March 3, 2023
BioMarin Pharmaceutical Q4 revenues $537.5 million - February 28, 2023
Strike action resumes at GSK pharmaceutical plant in Irvine, Scotland - February 6, 2023
Engineered BioPharmaceuticals creating 34 new jobs in Virginia - February 3, 2023
Sun Pharma to acquire Concert Pharmaceuticals - January 20, 2023
CNS Pharmaceuticals appoints Faith L. Charles as board chair - January 4, 2023
Granules India to establish pharmaceutical packaging facility in Virginia, create 57 new jobs - December 1, 2022
Biocytogen Pharmaceuticals enters antibody agreement with ADC Therapeutics - November 29, 2022
African Development Fund invests over $6 million to develop pharmaceutical sector in Southern and Eastern Africa - November 12, 2022
SEC charges pharmaceutical company chief information officer in $8 million insider trading scheme - November 11, 2022
Lotus Pharmaceutical reported best Q3 ever - November 11, 2022
Athens Pharmaceutical Association: Greek pharmacies lack essential medicine - October 27, 2022
Pfizer completes $11.6bn acquisition of Biohaven Pharmaceuticals - October 4, 2022
Phathom Pharmaceuticals appoints James Toppe to board - September 27, 2022
Rocket Pharmaceuticals to buy Renovacor in $53m deal - September 22, 2022
West Pharmaceutical Services creating 225 new, full-time jobs in Lycoming County, Pennsylvania - August 30, 2022
District Court enjoins Illinois pharmaceutical manufacturer from making and selling adulterated drugs - August 22, 2022
EU wins WTO case against Turkey's discriminatory practices on pharmaceuticals - July 26, 2022
Innoviva to acquire La Jolla Pharmaceutical Company - July 12, 2022
Precision Pharmaceuticals fined and directed to cease alleged unlawful advertising of nicotine vaping products - July 4, 2022
African Development Bank approves establishment of African Pharmaceutical Technology Foundation - June 27, 2022
Bexion Pharmaceuticals appoints Joyce LaViscount as CFO - June 3, 2022
International Process Plants buys Novartis UK's pharmaceutical manufacturing site - May 25, 2022
Mirum Pharmaceuticals acquires Satiogen Pharmaceuticals - May 25, 2022
CNS Pharmaceutical Q1 net loss $2.8 million - May 17, 2022
Taiho Pharmaceutical to buy Cullinan Pearl in up to $405m deal - May 14, 2022
Arrowhead Pharmaceuticals to create more than 230 high-paying jobs in Verona, Wisconsin - May 12, 2022
Pharmaceutical packaging market would surpass $155.3 billion - May 3, 2022
Hikma Pharmaceuticals acquires Custopharm for $425m - April 25, 2022
Micreos Pharmaceuticals' XZ.700 enzyme eliminates Staphylococcus aureus without triggering resistance - April 14, 2022
Fosun Pharmaceutical revenue increase 28.70% - March 23, 2022
Pharmaceutical crime: First Interpol-Afripol front-line operation sees arrests and seizures across Africa - March 9, 2022
Pharmaceutical company fined £51,000 for manufacturing defective medicine - March 3, 2022
North Carolina: West Pharmaceutical Services to add 70 new jobs in Lenoir County - February 3, 2022
Hikma Pharmaceutical acquires Teligent for $45.8 million - January 17, 2022
BeyondSpring Pharmaceuticals cuts 35% of its U.S. workforce - January 13, 2022
Currax Pharmaceuticals appoints Michael Kyle as SVP - January 11, 2022
Novo Nordisk completes acquisition of Dicerna Pharmaceuticals - December 29, 2021
Pfizer to buy Arena Pharmaceuticals for $6.7 billion - December 13, 2021
Armenia to roll out homegrown Liqvor Pharmaceuticals Sputnik Light vaccine - December 7, 2021
Novo Nordisk to acquire Dicerna Pharmaceuticals for 3.3 bln U.S. dollars - November 19, 2021
Oregon sues opioid manufacturer Endo Pharmaceuticals for deceptive marketing - November 13, 2021
PharmaMar signs licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan - November 11, 2021
Tonix Pharmaceuticals to open new center in Maryland - October 15, 2021
Micreos appoints Matt Regan as CEO of its pharmaceutical business - October 14, 2021
Ampio Pharmaceuticals appoints three experienced executives - October 14, 2021
Chugai Pharmaceutical files to expand use of COVID-19 antibody drug - October 11, 2021
Kazakhstan considering development of homemade pharmaceuticals against COVID-19 - September 3, 2021
Chugai Pharmaceutical ​obtains approval for COVID-19 antibody cocktail - July 20, 2021
Nexus Pharmaceuticals opens new manufacturing facility in Pleasant Prairie, Wisconsin - July 20, 2021
Visegrad countries sign agreement with France on pharmaceutical industries - June 22, 2021
Zimbabwe launches pharmaceutical manufacturing strategy to boost drug production - June 11, 2021
Morphosys to acquire Constellation Pharmaceuticals in $1.7 billion deal - June 2, 2021
Xeris Pharmaceuticals to buy Strongbridge Biopharma - May 25, 2021
Cumberland Pharmaceuticals promotes John Hamm to director - May 20, 2021
Hungary investigates pharmaceutical wholesaler system - March 22, 2021
FTC announces multilateral working group to build new approach to pharmaceutical mergers - March 17, 2021
La Jolla Pharmaceutical Q4 net sales $11.0 million - March 9, 2021
JCR Pharmaceuticals to build new plant to produce COVID-19 vaccine - March 4, 2021
Perrigo sells Generic Rx Pharmaceuticals for $1.55 billion - March 1, 2021
Jazz Pharmaceuticals to buy GW Pharmaceuticals for $7.2b - February 3, 2021
Pine Pharmaceuticals to expand in New York, create 40 jobs - January 26, 2021
EIB launches EUR 50 million Africa pharmaceutical initiative - December 18, 2020
Bora Pharmaceuticals selects Mississauga for its North American headquarters, employ 400 - December 3, 2020
German authorities bust international trading network for illegal pharmaceuticals - October 27, 2020
Bayer to acquire Asklepios BioPharmaceutical for as much as $4 billion - October 26, 2020
Several deaths linked to vaccines by SK Biopharmaceuticals - October 23, 2020
Parliament wants EU to tackle pharmaceutical pollution - September 18, 2020
Johnson and Johnson to acquire Momenta Pharmaceuticals in $6.5 billion deal - August 20, 2020
U.S. files false claims act complaint against Teva Pharmaceuticals alleging illegal kickbacks - August 18, 2020
Novartis Pharmaceuticals to pay $4.4 million to resolve medicaid fraud allegations - August 7, 2020
Germany: Pharmaceutical industry defies coronavirus crisis, exports up 14.3% - July 22, 2020
Uzbekistan bans export of pharmaceutical products - July 18, 2020
SEC charges Alexion Pharmaceuticals with FCPA violations - July 3, 2020
La Jolla Pharmaceutical Company to acquire Tetraphase Pharmaceuticals - June 24, 2020
Aridis Pharmaceuticals appoints Hasan Jafri as chief medical officer - June 15, 2020
Nobel laureate Honjo to sue Ono Pharmaceutical Co. for $207 million in patent royalties - June 6, 2020
Neurotrope and Metuchen Pharmaceuticals announce merger agreement - May 20, 2020
JCR Pharmaceuticals announces completion of acquisition of ArmaGen - April 27, 2020
AGs and FTC against Vyera Pharmaceuticals, Martin Shkreli, others - April 15, 2020
Zentalis Pharmaceuticals to get $165.2 million from initial public offering - April 3, 2020
Otsuka Canada Pharmaceutical resolved generic drugs problem - April 3, 2020
U.S. urges India to lift export ban on pharmaceutical ingredients - March 31, 2020
Menlo Therapeutics and Foamix Pharmaceuticals complete merger - March 9, 2020
Teva Pharmaceutical Q4 earnings $683 million - February 12, 2020
Unredacted information shows unbelievable greed of Teva Pharmaceuticals - February 11, 2020
Biohaven Pharmaceutical appoints Michael Heffernan to board - February 3, 2020
New York AG sues ‘Pharma Bro' Martin Shkreli and Vyera Pharmaceuticals for extreme prices - January 28, 2020
Biohaven Pharmaceutical Q2 net loss $211.1 million - January 14, 2020
Esteve acquires German pharmaceutical company Riemser - January 8, 2020
Sobi successfully completes tender offer for Dova Pharmaceuticals - November 11, 2019
Phoenix' Nomeco: Scandinavia's largest pharmaceutical logistics centre goes live - November 8, 2019
Teva Pharmaceuticals Q3 revenues $4,264 million - November 7, 2019
Vietnam's pharmaceutical import up 11.3 percent in 10 months - November 7, 2019
Merck Q3 pharmaceutical sales $11.1 billion - October 29, 2019
Primex Pharmaceuticals appoints Dan Spacie as global commercial head - October 24, 2019
UCB to acquire Ra Pharmaceuticals in $2.1 billion deal - October 10, 2019
Pakistan's competition commission warns pharmaceutical sector of anti-competitive practices - September 21, 2019
Lundbeck to acquire Alder BioPharmaceuticals in transaction valued at up to $1.95 billion - September 16, 2019
Iran signs $10m deal to export pharmaceuticals to Nicaragua - August 14, 2019
Jazz Pharmaceuticals to buy Cavion for up to $312.5 million - August 13, 2019
Teva Pharmaceutical Industries Q2 adjusted earnings beat estimates - August 7, 2019
Oklahoma: Johnson & Johnson are kingpin of pharmaceutical cartel - July 15, 2019
Jazz Pharmaceuticals buys Redx Pharma's pan-RAF inhibitor - July 10, 2019
Glenmark Pharmaceuticals to partner with Novartis in Brazil - June 24, 2019
KriGen Pharmaceuticals to employ, invest in Harnett County, N.C. - June 5, 2019
Dicerna Pharmaceuticals appoints Rob Ciappenelli as chief commercial officer - June 5, 2019
Heritage Pharmaceuticals to pay more than $7 million in criminal penalty and civil damages - June 1, 2019
Takeda Pharmaceutical FY18 profit down - May 14, 2019
Adial Pharmaceuticals appoints Alex Lugovoy as head of strategy - April 12, 2019
Three pharmaceutical companies to pay over $122m to resolve allegations that they paid kickbacks - April 4, 2019
Galmed Pharmaceuticals net loss $3.7 million, $0.18 per share - March 14, 2019
Marinus Pharmaceuticals appoints Scott Braunstein as executive chairman - February 27, 2019
Beximco Pharmaceuticals acquires 14 new drug applications from Sandoz - February 20, 2019
Phio Pharmaceuticals appoints Gerrit Dispersyn as CEO - February 18, 2019
Teva Pharmaceutical Q4 net loss $2.94 billion - February 14, 2019
Ultragenyx Pharmaceutical appoints Shehnaaz Suliman to board - February 5, 2019
Teva Pharmaceutical Industries to pay Illinois $135m fraud settlement - January 14, 2019
Dechra Pharmaceuticals appoints Lisa Bright as non-executive director - December 18, 2018
Chinese fish oil company Shandong Yuwang Pharmaceutical is Friend of the Sea - November 27, 2018
Hemogenyx Pharmaceuticals appoints Andrew Wright as company secretary - November 6, 2018
EIB backs Italian CNS drug developer Newron Pharmaceuticals with up to EUR 40m - October 30, 2018
Dechra Pharmaceuticals acquires animal medical supplier Caledonian - October 8, 2018
CASI Pharmaceuticals appoints George Chi as chief financial officer - October 1, 2018
SEC charges Salix Pharmaceuticals and former CFO With lying about distribution channel - September 29, 2018
Alexion Pharmaceuticals to buy biotech firm Syntimmune for up to $1.2 billion - September 26, 2018
Aralez Pharmaceuticals enters into 'stalking horse' deals for $240 million - September 20, 2018
Idera Pharmaceuticals appoints Howard Pien to board - September 19, 2018
Biopharmaceutical company, executives charged with misleading investors about cancer drug - September 18, 2018
Bison Capital Acquisition Corp. and Xynomic Pharmaceuticals sign merger agreement - September 13, 2018
Telix Pharmaceuticals completes acquisition of Atlab Pharma - September 12, 2018
Achillion Pharmaceuticals appoints Steven Zelenkofske as executive vice president - August 22, 2018
Spring Bank Pharmaceuticals adds Scott Smith to board - August 17, 2018
Cumberland Pharmaceuticals Q2 net revenues up 17% - August 15, 2018
Amneal Pharmaceuticals Q2 GAAP net revenue up 59.2% - August 10, 2018
Perrigo announces plan to separate Prescription Pharmaceuticals business - August 9, 2018
Juniper Pharmaceuticals to be acquired by Catalent - July 4, 2018
Aquestive Therapeutics settles patent infringement case with Par Pharmaceuticals - May 19, 2018
Aquinnah Pharmaceuticals appoints Travis T. Wager as vice president - May 16, 2018
Camargo Pharmaceutical Services appoints Daniel S. Duffy as new CEO - May 3, 2018
Zynerba Pharmaceuticals appoints John Butler to board - April 17, 2018
Paratek Pharmaceutical appoints Rolf K. Hoffman to board - April 16, 2018
DalCor Pharmaceuticals appoints Fouzia Laghrissi-Thode as CEO - April 10, 2018
Xenon Pharmaceuticals appoints Ernesto Aycardi as CMO - March 14, 2018
Tetraphase Pharmaceuticals promotes Larry Edwards to COO - March 5, 2018
West Pharmaceutical Services appoints Silji Abraham as SVP - February 27, 2018
Hikma Pharmaceuticals appoints Sigurdur Olafsson as CEO - February 21, 2018
Tonix Pharmaceuticals appoints General David L. Grange to board - February 16, 2018
Teva Pharmaceutical Industries profit falls in Q4 - February 8, 2018
Clementia Pharmaceuticals appoints Pierre Legault as director - February 1, 2018
Dova Pharmaceuticals appoints Mark W. Hahn as CFO - January 31, 2018
UPM Pharmaceuticals promotes Chris Curtin to COO - January 23, 2018
Tonix Pharmaceuticals appoints Jessica Morris as COO - January 10, 2018
Peregrine Pharmaceuticals appoints Roger J. Lias as CEO - December 27, 2017
Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2 billion - December 26, 2017
Concert Pharmaceuticals appoints Marc Becker as CFO - December 20, 2017
Synergy Pharmaceuticals appoints Troy Hamilton as CEO - December 20, 2017
Apellis Pharmaceuticals appoints Timothy Sullivan as CFO - December 20, 2017
Agios Pharmaceuticals appoints Jacqualyn Fouse to board - December 6, 2017
SCA Pharmaceuticals opens 90,000 square foot production facility - December 4, 2017
Sunesis Pharmaceuticals appoints William Quinn as CFO - December 1, 2017
Peregrine Pharmaceuticals appoints Patrick Walsh to board - October 25, 2017
Peregrine Pharmaceuticals appoints Mark R. Bamforth to boards - October 20, 2017
Avara Pharmaceutical Services buys consumer healthcare facility from GSK - September 25, 2017
Aegerion Pharmaceuticals paying penalty for misleading investors about sales - September 23, 2017
Mallinckrodt Pharmaceuticals elects David Norton to board - September 21, 2017
Eton Pharmaceuticals appoints Paul V. Maier to board - September 15, 2017
Tonix Pharmaceuticals appoints Margaret Smith Bell to board - September 15, 2017
Achillion Pharmaceuticals promotes Joseph Truitt to COO - September 12, 2017
Opiant Pharmaceuticals appoints David O’Toole as CFO - September 6, 2017
Rigel Pharmaceuticals appoints Brian L. Kotzin to board - August 28, 2017
Ligand Pharmaceuticals appoints Nancy Ryan Gray to board - August 22, 2017
Peregrine Pharmaceuticals cuts 20% of workforce to reduce costs - August 15, 2017
Pharmaceuticals sector posts sharp output growth in Europe - August 9, 2017
Teva Pharmaceutical Industries posts 15% fall in Q2 earnings - August 3, 2017
Bruk Herbst joins Zomedica Pharmaceuticals as CCO - July 12, 2017
Foamix Pharmaceuticals names David Domzalski as CEO - June 30, 2017
Adamas Pharmaceuticals names Alfred G. Merriweather as CFO - June 29, 2017
Eton Pharmaceuticals appoints Sean Brynjelsen as CEO - June 26, 2017
Pacira Pharmaceuticals appoints Mark I. Froimson to board - June 16, 2017
Syros Pharmaceuticals appoints Srinivas Akkaraju to board - June 13, 2017
RXi Pharmaceuticals appoints Jonathan Freeman as director - June 8, 2017
Collegium Pharmaceutical appoints Joseph Ciaffoni as COO - May 31, 2017
BioCryst Pharmaceuticals appoints Robert A. Ingram as chairman - May 31, 2017
Hanmi Pharmaceuticals employees, investors fined for violating stock trading rules - May 25, 2017
Eagle Pharmaceuticals appoints Pete A. Meyers as CFO - May 16, 2017
Baytacare Pharmaceutical nominates two directors - May 15, 2017
Marinus Pharmaceuticals appoints Lorianne K. Masuoka as CMO - April 13, 2017
Ultragenyx Pharmaceutical appoints Deborah Dunsire to board - April 11, 2017
Ironwood Pharmaceuticals appoints Christopher Wright as SVP - April 10, 2017
Syndax Pharmaceuticals appoints Keith A. Katkin to board - April 6, 2017
Alder BioPharmaceuticals appoints Wendy L. Yarno as director - April 6, 2017
Actinium Pharmaceuticals appoints Ajit Shetty to board - March 29, 2017
Alexion Pharmaceuticals appoints Ludwig N. Hantson as CEO - March 28, 2017
Reata Pharmaceuticals appoints vice president - March 27, 2017
Cipher Pharmaceuticals appoints Robert D. Tessarolo as CEO - March 22, 2017
Oramed Pharmaceuticals appoints Ronald Law as CSO - March 22, 2017
Arena Pharmaceuticals names Preston Klassen as EVP, CMO - March 21, 2017
Eagle Pharmaceuticals names Richard A. Edlin to board - March 17, 2017
GW Pharmaceuticals appoints Scott Giacobello as CFO - March 8, 2017
Aurinia Pharmaceuticals appoints CEO - February 8, 2017
EyeGate Pharmaceuticals appoints three executives - February 8, 2017
Bellicum Pharmaceuticals names Rick Fair as CEO - February 1, 2017
Endo Pharmaceuticals to abandon anticompetitive pay-for-delay agreements - January 31, 2017
X4 Pharmaceuticals names Sudha Parasuraman as chief medical officer - January 24, 2017
GlaxoSmithKline: Luke Miels appointed president, global pharmaceuticals - January 20, 2017
Eli Lilly to acquire CoLucid Pharmaceuticals for $960m - January 18, 2017
NovaBay Pharmaceuticals Q4 sales increased 146% to $3.8 million - January 10, 2017
Takeda to acquire Ariad Pharmaceuticals in $5.2 billion deal - January 9, 2017
AMAG Pharmaceuticals appoints Brian Kelley to board - December 22, 2016
Aerie Pharmaceuticals appoints chief commercial officer - December 21, 2016
Eagle Pharmaceuticals names David Pernock chief commercial officer - December 21, 2016
Former top Heritage Pharmaceuticals executives charged with conspiracies - December 14, 2016
Peregrine Pharmaceuticals Q2 2017 manufacturing revenues up 53% - December 13, 2016
Aquinnah Pharmaceuticals appoints two executives - November 25, 2016
Enanta Pharmaceuticals appoints new board member - November 23, 2016
Atrin Pharmaceuticals appoints board member - November 22, 2016
Novartis buys Selexys Pharmaceuticals in $665 million deal - November 21, 2016
Nuvo Pharmaceuticals appoints Jesse Ledger as president - November 17, 2016
Cipher Pharmaceuticals names Stephen L. Lemieux interim CEO - November 14, 2016
Eagle Pharmaceuticals to buy Arsia Therapeutics in $78 million deal - November 12, 2016
Dechra Pharmaceuticals names non-executive director - November 10, 2016
GW Pharmaceuticals to cancel London listing, will stay on Nasdaq - October 19, 2016
Inovio Pharmaceuticals appoints three vice presidents - October 13, 2016
X4 Pharmaceuticals names Nancy Lurker as chair of board - October 6, 2016
Momenta Pharmaceuticals adds Corey N. Fishman to board - September 26, 2016
Kleo Pharmaceuticals names chief scientific officer - September 23, 2016
Concert Pharmaceuticals appoints two vice presidents - September 12, 2016
Sunovion Pharmaceuticals to acquire Cynapsus Therapeutics - September 5, 2016
Agios Pharmaceuticals chairman Marc Tessier-Lavigne to resign - August 29, 2016
Dechra Pharmaceuticals appoints Richard Cotton as CFO - August 18, 2016
Agios Pharmaceuticals appoints CFO - August 17, 2016
Endo names Joseph Ciaffoni as president, U.S. branded pharmaceuticals - August 9, 2016
Perrigo announces leadership change in Rx pharmaceuticals segment - July 22, 2016
AMAG Pharmaceuticals appoints VP, market access & corporate accounts - July 14, 2016
Dechra Pharmaceuticals full-year revenue jumps 21% - July 12, 2016
Blackberry and avocado residues great for pharmaceutical industry - July 9, 2016
Biogen names EVP, pharmaceutical operations & technology - June 22, 2016
X4 Pharmaceuticals appoints John K. Celebi as COO - June 15, 2016
Merck to acquire Afferent Pharmaceuticals in $1.25 billion deal - June 11, 2016
Valeant Pharmaceuticals receives default notice - June 3, 2016
Pfizer to buy Anacor Pharmaceuticals in $5.2 billion deal - May 16, 2016
OPKO names SVP, pharmaceutical marketing and market access - May 12, 2016
NovaBay Pharmaceuticals appoints Todd Zavodnick to board - May 11, 2016
Teva Pharmaceutical Q1 revenues down 3 percent - May 10, 2016
La Jolla Pharmaceutical Q1 net loss $16.5 million - May 9, 2016
Catabasis Pharmaceuticals CFO Ian Sanderson to resign - April 7, 2016
Keryx Biopharmaceuticals appoints two directors - April 4, 2016
Immune Pharmaceutical Q4 loss $8.2 million, $0.27 per share - April 1, 2016
FTC sues Endo Pharmaceuticals, 7 others for blocking lower-cost generics - March 31, 2016
Valeant Pharmaceuticals CEO, directors ordered to cease trading - March 31, 2016
AcelRx Pharmaceuticals names Howard B. Rosen permanent CEO - March 30, 2016
AVEO Pharmaceuticals pays $4m to settle SEC fraud charges - March 29, 2016
Sunesis Pharmaceuticals appoints Geoffrey Parker to board - March 29, 2016
Juniper Pharmaceuticals appoints Mary Ann Gray to board - March 25, 2016
Sagent Pharmaceuticals names Sean Brynjelsen EVP - March 25, 2016
CoLucid Pharmaceuticals appoints Alison Lawton to board - March 17, 2016
Remedy Pharmaceuticals appoints VP - March 16, 2016
Valeant Pharmaceuticals expect 2016 revenue to be $11 - $11.2 billion - March 15, 2016
Inovio Pharmaceuticals adds David B. Weiner to board - March 14, 2016
Synergy Pharmaceuticals names Marino Garcia as EVP - March 14, 2016
Juniper Pharmaceuticals Q4 total revenues increased to $7.6 million - March 11, 2016
Momenta Pharmaceuticals names new board member - March 11, 2016
Paratek Pharmaceuticals names Kris Peterso as director - March 8, 2016
NovaBay Pharmaceuticals Q4 net sales $1.6 million - March 7, 2016
Cipher Pharmaceuticals appoints Ralph Bohrer as U.S. president - March 7, 2016
West Pharmaceutical Services appoints Eric Resnick as vice president - March 2, 2016
Aegerion Pharmaceuticals Q4 total net product sales $49 million - February 26, 2016
Hikma Pharmaceuticals names John J. Castellani as director - February 23, 2016
AMAG Pharmaceuticals Q4 total revenues $108.7 million - February 18, 2016
Aegerion Pharmaceuticals to cut 25% of global workforce - February 11, 2016
Agios Pharmaceuticals names chief commercial officer - February 9, 2016
Pozen and Tribute combine to create Aralez Pharmaceuticals - February 8, 2016
Aoxing Pharmaceutical appoints James Chen as CFO - February 3, 2016
Collegium Pharmaceutical appoints Ted Schroeder to board - January 26, 2016
Vanc Pharmaceuticals appoints David M. Hall to board - January 22, 2016
ACADIA Pharmaceuticals adds Jim Daly to board - January 13, 2016
Inotek Pharmaceuticals names Carsten Boess to board - January 13, 2016
ARIAD Pharmaceuticals elects Alexander Denner as chairman - January 12, 2016
AMAG Pharmaceuticals expects Q4 non-GAAP product revenue of $124 million - January 12, 2016
Howard B. Schiller interim CEO of Valeant Pharmaceuticals - January 7, 2016
Vanc Pharmaceuticals CEO Arun Nayyar joins board - December 31, 2015
KaloBios Pharmaceuticals files for Chapter 11 bankruptcy - December 30, 2015
Jochen Gann joins Hikma Pharmaceuticals board - December 28, 2015
Aeolus Pharmaceuticals net loss $2,628,000 - December 22, 2015
Turing Pharmaceuticals names Ron Tilles interim CEO - December 21, 2015
Threshold Pharmaceuticals to reduce workforce by two-thirds - December 21, 2015
Sun Pharmaceutical receives warning letter from FDA - December 21, 2015
Valeant Pharmaceuticals expects total revenue $12.5 - $12.7 billion - December 16, 2015
Fennec Pharmaceuticals appoints Khalid Islam as chairman - December 10, 2015
Momenta Pharmaceuticals names Matthew P. Ottmer as COO - December 8, 2015
Forum Pharmaceuticals appoints George Parker as CHRO - December 7, 2015
XTL Biopharmaceuticals Q3 loss $443,000 - December 3, 2015
ACADIA Pharmaceuticals appoints EVP, head of research and development - December 1, 2015
Lannett completes $1.23 billion Kremers Urban Pharmaceuticals deal - November 28, 2015
Vertex Pharmaceuticals elects Michael J. Parini as EVP - November 24, 2015
InMed Pharmaceuticals appoints Adam Cutler to board - November 24, 2015
West Pharmaceutical Services appoints SVP - November 20, 2015
Synergy Pharmaceuticals names Gary Sender EVP and CFO - November 17, 2015
Immune Pharmaceuticals had $9 million in cash in Q3 - November 13, 2015
EPIRUS Biopharmaceuticals appoints chief business officer - November 11, 2015
Anthera Pharmaceuticals Q3 net loss $11.3 million - November 9, 2015
La Jolla Pharmaceutical Q3 net loss $10.5 million - November 7, 2015
Sanofi and Hanmi Pharmaceutical in worldwide license agreement - November 6, 2015
Teva Pharmaceutical Industries Q3 revenues $4.8 billion - October 30, 2015
Arena Pharmaceuticals to lay off 35 percent of U.S. workforce - October 28, 2015
Syros Pharmaceuticals appoints Marsha H. Fanucci to board - October 21, 2015
Valeant Pharmaceuticals Q3 total revenues increase 36% - October 19, 2015
Valeant Pharmaceuticals completes tender offer for Synergetics - October 15, 2015
IGI Laboratories to buy Alveda Pharmaceuticals for $47 million CAD - October 14, 2015
Scynexis appoints VP, pharmaceutical development - October 9, 2015
Endo completes $8.05 billion acquisition of Par Pharmaceutical - September 28, 2015
ANI Pharmaceuticals to buy two products from Merck for $75+ million - September 22, 2015
Syros Pharmaceuticals appoints Kyle Kuvalanka as COO - September 22, 2015
ACADIA Pharmaceuticals appoints Steve Davis as CEO - September 4, 2015
Lannett to acquire Kremers Urban Pharmaceuticals for $1.23 billion - September 4, 2015
Anthony Principi joins Imprimis Pharmaceuticals board - September 3, 2015
Valeant Pharmaceuticals to acquire Synergetics USA - September 3, 2015
InMed Pharmaceuticals appoints Paul Brennan to board - August 26, 2015
AMAG Pharmaceuticals appoints Joseph Vittiglio as SVP - August 26, 2015
Acura Pharmaceuticals goes for 1-for-5 reverse stock split - August 26, 2015
Tivorsan Pharmaceuticals elects James E. Connolly as CEO - August 19, 2015
Catalyst Pharmaceuticals appoints chief commercial officer - August 18, 2015
Cloud Pharmaceuticals adds two C-level executives to its board - August 18, 2015
Immune Pharmaceuticals Q2 net loss $2.9 million - August 18, 2015
Parnell Pharmaceuticals elects Peter A. Croden to board - August 12, 2015
La Jolla Pharmaceutical Q2 net loss $10.7 million - August 10, 2015
BioCryst Pharmaceuticals adds Robert A. Ingram to board - August 10, 2015
Kolltan Pharmaceuticals appoints Ronald A. Peck as SVP - August 7, 2015
Ohr Pharmaceutical promotes Jason S. Slakter to CEO - August 6, 2015
Allergan and Kythera Biopharmaceuticals amended their merger deal - August 6, 2015
Juniper Pharmaceuticals Q2 revenues $10.2 million, 53% better - August 5, 2015
Inotek Pharmaceuticals names Cadmus Collins Rich vice president - July 24, 2015
Lupin to buy GAVIS Pharmaceuticals for $880 million - July 24, 2015
Inotek Pharmaceuticals names Claudine Prowse as vice president - July 21, 2015
Ultragenyx Pharmaceutical appoints John Pinion as SVP - July 21, 2015
Valeant to acquire Amoun Pharmaceutical for $800 million - July 18, 2015
Peregrine Pharmaceuticals Q4 total revenues $9,308,000 - July 15, 2015
CoLucid Pharmaceuticals appoints Marvin L. White to board - July 14, 2015
ANI Pharmaceuticals buys 22 generic drugs from Teva for $25 million - July 14, 2015
Synergy Pharmaceuticals appoints chief commercial officer - July 10, 2015
Joseph Krivulka and Martin Simonetti join Prismic Pharmaceuticals - July 2, 2015
AMAG Pharmaceuticals to acquire Cord Blood Registry for $700 million - July 1, 2015
Gregory D. Perry new CFO of Aegerion Pharmaceuticals - June 29, 2015
Novartis to buy Spinifex Pharmaceuticals to focus on neuropathic pain - June 29, 2015
Momenta Pharmaceuticals CFO Richard P. Shea to step down - June 26, 2015
Alexion Pharmaceuticals adds Felix J. Baker to board - June 24, 2015
Allergan to buy Kythera Biopharmaceuticals for $2.1 billion - June 17, 2015
AMAG Pharmaceuticals appoints Aaron Pelta VP, business development - June 11, 2015
XTL Biopharmaceuticals Q1 operating loss $0.3 million - June 2, 2015
Juniper Pharmaceuticals adds James A. Geraghty to board - May 29, 2015
Xenon Pharmaceuticals appoints Steven Gannon to board - May 25, 2015
Endo International to buy Par Pharmaceutical for $8 billion - May 18, 2015
Takeda Pharmaceutical underlying revenue increased 2.8% - May 16, 2015
M Pharmaceutical appoints Christopher Andrews as director - May 15, 2015
Kala Pharmaceuticals selects Mark Iwicki as chairman - May 15, 2015
NovaBay Pharmaceuticals Q1 product revenue $492,000 - May 15, 2015
Alexion Pharmaceuticals to buy Synageva BioPharma for $8.4 billion - May 6, 2015
Teva completes $3.5 billion acquisition of Auspex Pharmaceuticals - May 6, 2015
Syros Pharmaceuticals appoints three senior executives - May 4, 2015
Keryx Biopharmaceuticals elects John F. Neylan as CMO - April 27, 2015
Catabasis Pharmaceuticals appoints Ted Hibben as SVP - April 27, 2015
Allena Pharmaceuticals appoints Louis Brenner as COO - April 17, 2015
Tetraphase Pharmaceuticals appoints Gerri Henwood to board - April 17, 2015
scPharmaceuticals elects director and new CFO - April 15, 2015
Valeant completes acquisition of Salix Pharmaceuticals - April 2, 2015
CASI Pharmaceuticals loss $1.6 million - March 30, 2015
Sagent Pharmaceuticals announces leadership changes - March 27, 2015
EPIRUS Biopharmaceuticals net loss $10.4 million - March 24, 2015
Deciphera Pharmaceuticals appoints CFO - March 17, 2015
KaloBios Pharmaceuticals net loss $38 million - March 17, 2015
Anthera Pharmaceuticals Q4 net loss $7.4 million - March 17, 2015
AcelRx Pharmaceuticals Q4 net loss 13.8 million - March 11, 2015
Baxter acquires biopharmaceutical company SuppreMol from Germany - March 7, 2015
Tetraphase Pharmaceuticals appoints Maria Stahl as SVP - March 6, 2015
InMed Pharmaceuticals appoints chief medical officer - March 5, 2015
Biota Pharmaceuticals to buy Anaconda Pharma of France - February 28, 2015
Valeant to buy Salix Pharmaceuticals for $14.5 billion - February 23, 2015
Vanda Pharmaceuticals jumps from $8.8 million to $15.4 million - February 23, 2015
Aegerion Pharmaceuticals completes $325 million acquisition of Myalept - January 14, 2015
Biogen Idec to buy Convergence Pharmaceuticals of UK for up to $675m - January 14, 2015
Tekmira Pharmaceuticals and OnCore Biopharma to create leading Hepatitis B company - January 13, 2015
Sarah Boyce joins Isis Pharmaceuticals - January 8, 2015
Hikma Pharmaceuticals names Pamela Kirby director - November 10, 2014
Patrick Vink new COO of Cubist Pharmaceuticals - November 6, 2014
Impax president of global pharmaceuticals departs - October 23, 2014
Cubist Pharmaceuticals selects Robert Perez as CEO - October 21, 2014
Tokai Pharmaceuticals names VP - August 29, 2014
Livzon Pharmaceutical appoints Desheng Tao as vice chairman - August 27, 2014
Inotek Pharmaceuticals appoints David P. Southwell as CEO - August 18, 2014
Rock Creek Pharmaceuticals expands the board - August 7, 2014
Baxter names CFO for new biopharmaceutical spin-off - July 10, 2014
Aerie Pharmaceuticals names VP, business development - June 23, 2014
Aerie Pharmaceuticals elects new board member - June 13, 2014
AMAG Pharmaceuticals names SVP of business development and strategy - June 12, 2014
Ampio Pharmaceuticals appoints Gregory A. Gould as CFO - June 6, 2014
Ironwood Pharmaceuticals appoints new director - June 5, 2014
GW Pharmaceuticals appoints VP, clinical science - May 7, 2014
Alexion Pharmaceuticals appoints John T. Mollen to board - April 22, 2014
Gino Santini new chairman of AMAG Pharmaceuticals - April 17, 2014
Anthera Pharmaceuticals announces personnel changes - April 2, 2014
Portola Pharmaceuticals adds John Johnson to board - March 19, 2014
Beximco Pharmaceuticals appoints two directors - March 14, 2014
Hikma Pharmaceuticals changes organisational structure - March 14, 2014
Synta Pharmaceuticals CEO resigns - March 5, 2014
Jazz Pharmaceuticals announces management change - February 26, 2014
West Pharmaceutical Services adds new director - February 24, 2014
Sihuan Pharmaceutical Holdings appoints Xun Zhu as director - February 20, 2014
Peggy Phillips new director at Tekmira Pharmaceuticals - February 13, 2014
SciClone Pharmaceuticals appoints Charles Meng as VP - February 12, 2014
Hikma Pharmaceuticals changes its board - February 12, 2014
Director Ed Torr to leave Dechra Pharmaceuticals - January 30, 2014
Kala Pharmaceuticals appoints chairman - January 7, 2014
Francesco Granata joins Prismic Pharmaceuticals board - December 4, 2013
Ra Pharmaceuticals names chief business officer - October 1, 2013
Cardioxyl Pharmaceuticals appoints chief medical officer - September 16, 2013
Osmotica Pharmaceutical appoints Steve Banet as vice president - August 26, 2013
Michael Hall senior vice president at Ironwood Pharmaceuticals - August 22, 2013
Terrence Moore new EVP at Acadia Pharmaceutical - August 20, 2013
Cadence Pharmaceuticals appoints Laureen DeBuono to its board - August 16, 2013
Elite Pharmaceuticals appoints president and CEO - August 6, 2013
Aerie Pharmaceuticals names president and COO - August 6, 2013
Aerie Pharmaceuticals appoints Vicente Anido, Jr. as CEO - July 29, 2013
Endo names COO of Pharmaceuticals - July 23, 2013
Michael S. Holfinger joins Alexza Pharmaceuticals - June 26, 2013
Tris Pharma hires president for generic pharmaceuticals business - June 21, 2013
Kurt Gustafson EVP, CFO at Spectrum Pharmaceuticals - June 6, 2013
Synergy Pharmaceuticals appoints chief medical officer - May 30, 2013
Kala Pharmaceuticals appoints EVP, business development - May 29, 2013
Heather Ann McSharry director of Jazz Pharmaceuticals - May 9, 2013
RXi Pharmaceuticals adds two to board of directors - April 23, 2013
Vanda Pharmaceuticals appoints chief medical officer - April 18, 2013
Beximco Pharmaceuticals appoints non-executive director - April 5, 2013
Pharmaceutical Product Development names SVP, global quality and compliance - March 26, 2013
Sagent Pharmaceuticals appoints James M. Hussey as president - March 22, 2013
New international marketing director at Britannia Pharmaceuticals - March 20, 2013
Optimer Pharmaceuticals appoints board chairman as CEO - March 1, 2013
GW Pharmaceuticals appoints Cabot Brown as non-executive director - February 20, 2013
Onyx Pharmaceuticals appoints Pablo J. Cagnoni as executive vice president - February 18, 2013
NeuroVive Pharmaceutical appoints Jan Nilsson as chief operating officer - February 1, 2013
Rexahn Pharmaceuticals appoints Peter D. Suzdak as CEO - January 23, 2013
Alexza Pharmaceuticals appoints J. Kevin Buchi to its board of directors - January 4, 2013
Valeant Pharmaceuticals names Laizer D. Kornwasser company group chairman - January 3, 2013
Omni Bio Pharmaceutical appoints Bruce E. Schneider as CEO - December 21, 2012
Onyx Pharmaceuticals elected chairman of its board of directors - December 18, 2012
Dechra Pharmaceuticals appoints two independent non-executive directors - December 13, 2012
Star Pharmaceutical elects Gu Yan to the board - November 30, 2012
Valeant Pharmaceuticals appoints two senior managers - November 29, 2012
Fedora Pharmaceuticals appoints two directors - October 31, 2012
Sun Jun deputy general manager at Tianjin Zhongxin Pharmaceutical Group - October 26, 2012
Tianjin Zhongxin Pharmaceutical Group appoints Wang Zhi Qiang as chairman - October 24, 2012
Star Pharmaceutical appoints Xu Zhi Bin as executive director and chairman - October 24, 2012
AMRI promotes Steven R. Hagen to SVP, pharmaceutical development and manufacturing - October 23, 2012
Biopharmaceutical executive Alan Lewis appointed as CEO of Medistem - October 9, 2012
GW Pharmaceuticals appoints Christopher John Tovey as chief operating officer - October 1, 2012
McKesson announces new president of U.S. pharmaceutical business - September 25, 2012
Vertex Pharmaceuticals elects Yuchun Lee to the board - September 19, 2012
Simcere Pharmaceutical Group names Hongquan Liu as CEO - September 14, 2012
Raptor Pharmaceutical appoints two senior managers - September 11, 2012
Catherine Sohn joins Jazz Pharmaceuticals - July 31, 2012
Merrimack Pharmaceuticals adds new director - July 17, 2012
Kala Pharmaceuticals appoints Guillaume Pfefer as president, CEO - July 13, 2012
Louis Ferrari new CEO of Savient Pharmaceuticals - July 10, 2012
Onyx Pharmaceuticals names John E. Osborn SVP, global corporate affairs - July 9, 2012
Arena Pharmaceuticals announces promotion - July 6, 2012
Cubist Pharmaceuticals promotes Robert J. Perez as president and COO - July 3, 2012
Silvia Taylor senior vice president at Sucampo Pharmaceuticals - June 29, 2012
RXi Pharmaceuticals appoints two new directors - June 22, 2012
Inovio Pharmaceuticals: Angel Cabrera joins the board - June 18, 2012
John A. MacPhee resigns from Strativa Pharmaceuticals - December 20, 2010
Pier Pharmaceuticals: Peter Letendre new CEO - December 17, 2010
Changes at Valeant Pharmaceuticals - December 13, 2010
Furiex Pharmaceuticals adds Stephen W. Kaldor to the board - December 10, 2010
Alnylam Pharmaceuticals adds Marsha H. Fanucci to the board - December 9, 2010
Catabasis Pharmaceuticals: Michael Ross named chairman - December 9, 2010
La Jolla Pharmaceutical appoints Bertrand C. Liang to the board - December 7, 2010
Synta Pharmaceuticals appoints two senior executives - December 2, 2010
NPS Pharmaceuticals adds Pedro Granadillo to the board - November 18, 2010
Topaz Pharmaceuticals: Bob Radie new president and CEO - November 18, 2010
Greg Divis new chief executive officer of K-V Pharmaceutical - November 18, 2010
Iroko Pharmaceuticals adds David C. U'Prichard to the board - November 17, 2010
Vanda Pharmaceuticals appoints chief financial officer - November 12, 2010
Tonix Pharmaceuticals adds Ernest Mari to the board - November 8, 2010
Idenix Pharmaceuticals: Ronald C. Renaud, Jr. new CEO - October 29, 2010
Idera Pharmaceuticals: Sudhir Agrawal new chairman - October 29, 2010
Kythera Biopharmaceuticals adds Francois Kress to the board - October 27, 2010
Transdel Pharmaceuticals appoints John N. Bonfiglio as CEO and president - October 21, 2010
Spectrum Pharmaceuticals: Brett L. Scott acting chief financial officer - October 12, 2010
Ligand Pharmaceuticals adds Sunil Patel to the board of directors - October 8, 2010
NGM Biopharmaceuticals: William J. Rieflin CEO and director - October 6, 2010
Synta Pharmaceuticals adds Donald Kufe to the board - September 30, 2010
Tigris Pharmaceuticals: Neil Flanzraich executive chairman - September 29, 2010
Calistoga Pharmaceuticals appoints Andrew Guggenhime as CFO - September 28, 2010
Lotus Pharmaceuticals announces senior management appointments - September 24, 2010
Portola Pharmaceuticals appoints Jean-Jacques Bienaime to board of directors - September 23, 2010
Alnylam Pharmaceuticals adds Steven M. Paul to the board - September 23, 2010
Somaxon Pharmaceuticals adds Faheem Hasnain to the board - September 21, 2010
Itero Biopharmaceuticals: Debanjan Ray new vice president - September 16, 2010
Rexahn Pharmaceuticals adds Peter Brandt and Richard Kivel to the board - September 13, 2010
Aegerion Pharmaceuticals appoints Marc Beer as CEO - September 13, 2010
Bausch + Lomb names Daniel M. Wechsler as global president, pharmaceuticals - September 13, 2010
Momenta Pharmaceuticals announces change to board of directors - September 13, 2010
Inspire Pharmaceuticals: Robert M. Savel, II, new senior vice president - September 1, 2010
Lee Hendelson joins Easton Pharmaceuticals - August 30, 2010
China Nuokang Bio-Pharmaceutical appoints Huining Cao to board - August 26, 2010
NovaBay Pharmaceuticals announces resignation of board member - August 25, 2010
Inspire Pharmaceuticals: Charles Johnson new EVP - August 13, 2010
Avid Radiopharmaceuticals: Mark A. Mintun chief medical officer - August 11, 2010
Concert Pharmaceuticals: Gregory L. Miller new head of business development - August 11, 2010
Poniard Pharmaceuticals: Mike Jackson named Interim CFO - August 10, 2010
K-V Pharmaceutical: Robert Baldini new independent director - August 10, 2010
Renhuang Pharmaceuticals: CFO Yan Yi Chen resigns - August 7, 2010
Paul McGarty new president for Lupin Pharmaceuticals - August 4, 2010
Aragon Pharmaceuticals appoints Richard A. Heyman CEO - August 2, 2010
Penwest Pharmaceuticals: Kevin C. Tang new chairman of the board - August 2, 2010
Caraco Pharmaceutical Laboratories appoints chief operating officer - July 28, 2010
Adeona Pharmaceuticals: Julie A. Caudill new vice president of finance - July 27, 2010
Patrick J. Zenner elected to the board of Par Pharmaceutical - July 23, 2010
Joseph Feczko joins Keryx Biopharmaceuticals - July 21, 2010
Spectrum Pharmaceuticals appoints George Tidmarsh as senior vice president - July 19, 2010
Berlin Pharmaceutical Industry: Amal Naj Chief new CEO and director - July 14, 2010
Vertex Pharmaceuticals adds Wayne J. Riley to the board - July 14, 2010
Amneal Pharmaceuticals appoints Shankar Hariharan as chief scientific officer - July 9, 2010
K-V Pharmaceutical adds David Sidransky to the board - July 7, 2010
West Pharmaceutical Services: Jeffrey C. Hunt new vice president - July 6, 2010
Vanda Pharmaceuticals adds Steven Galson to its board of directors - July 1, 2010
ARIAD Pharmaceuticals: Timothy P. Clackson president of R&D - June 24, 2010
Spectrum Pharmaceuticals: James E. Shields new chief commercial officer - June 23, 2010
Idera Pharmaceuticals adds Eve E. Slater to the board - June 21, 2010
K-V Pharmaceutical adds Ana Stancic to the board - June 19, 2010
Bohai Pharmaceuticals: Gene Hsiao new CFO - June 10, 2010
Progenics Pharmaceuticals: Peter J. Crowley new chairman - June 10, 2010
Paul L. Berns joins Jazz Pharmaceuticals - June 7, 2010
Alexion Pharmaceuticals adds Ann M. Veneman to the board - June 1, 2010
Oramed Pharmaceuticals: Michael Berelowitz new director - May 18, 2010
Qualitest Pharmaceuticals adds Ronald Johnson to the board - May 13, 2010
Threshold Pharmaceuticals: Eric D. Malek to lead corporate development - May 6, 2010
Akrimax Pharmaceuticals: Neil Larimer new vice president - May 6, 2010
FoldRx Pharmaceuticals: Georges Gemayel executive chairman - May 5, 2010
Avanir Pharmaceuticals: Michael McFadden new vice president - May 3, 2010
CPEX Pharmaceuticals adds Robert Forrester to the board - May 1, 2010
AMAG Pharmaceuticals appoints Gary J. Zieziula as EVP and chief commercial officer - April 28, 2010
Vanda Pharmaceuticals adds Vincent Milano to the board - April 21, 2010
Renhuang Pharmaceuticals appoints two independent directors - April 20, 2010
Somaxon Pharmaceuticals: Tran B. Nguyen new CFO - April 17, 2010
ALDA Pharmaceuticals appoints medical director - April 17, 2010
Patheon names Mark Kontny president of global pharmaceutical development services - April 15, 2010
ARIAD Pharmaceuticals adds Robert Whelan, Jr. to the board - April 15, 2010
K-V Pharmaceutical appoints Stephen A. Stamp as new CFO - April 13, 2010
Idenix Pharmaceuticals adds Tamar D. Howson to the board - March 31, 2010
Cadence Pharmaceuticals appoints Michael L. Eagle to the board - March 30, 2010
Omthera Pharmaceuticals names George Horner as chairman - March 29, 2010
Tianyin Pharmaceutical appoints James Jiayuan Tong as CFO - March 29, 2010
OncoGenex adds biopharmaceutical industry veterans to the board - March 24, 2010
MiddleBrook Pharmaceuticals announces board of directors resignations - March 24, 2010
Anthera Pharmaceuticals: Georgina Kilfoil senior vice president - March 24, 2010
Rib-X Pharmaceuticals appoints Mark Leuchtenberger as president and CEO - March 23, 2010
Regeneron Pharmaceuticals: Michael Aberman new vice president - March 23, 2010
Endo Pharmaceuticals appoints new COO - March 12, 2010
Manhattan Pharmaceuticals acquires Ariston Pharmaceuticals, names new management - March 12, 2010
Genetix Pharmaceuticals: Mitchell Finer chief scientific officer - March 12, 2010
Portola Pharmaceuticals announces management changes - March 11, 2010
Teva Pharmaceutical Industries: Philip Frost new chairman of the board - March 9, 2010
Kinex Pharmaceuticals: Charles E. Lannon vice-chairman of the board - March 5, 2010
China Yongxin Pharmaceuticals announces four new directors - March 5, 2010
Avrio Biopharmaceuticals: Yvonne Verburgt VP of business development and marketing - March 3, 2010
Transdel Pharmaceuticals appoints Terry Nida as chief business officer - March 1, 2010
Ancora Pharmaceuticals adds Barry C. Buckland to the board - February 26, 2010
Kinex Pharmaceuticals named Rudolf Kwan as chief medical officer - February 25, 2010
Alnara Pharmaceuticals: Thomas Rowland new vice president - February 25, 2010
OncoGenex Pharmaceuticals announces departure of CFO - February 25, 2010
Simcere Pharmaceutical appoints new president - February 25, 2010
Cubist Pharmaceuticals adds Lonnie Moulder to the board - February 22, 2010
Alexza Pharmaceuticals promotes Mark K. Oki to vice president - February 22, 2010
King Pharmaceuticals appoints two new members to its board - February 10, 2010
Neuraltus Pharmaceuticals: Andrew Gengos president and CEO - February 8, 2010
Anthera Pharmaceuticals adds Daniel K. Spiegelman to the board - February 8, 2010
Questcor Pharmaceuticals: Jason Zielonka new CMO - February 4, 2010
Poniard Pharmaceuticals: Ronald A. Martell new CEO - February 4, 2010
Tekmira Pharmaceuticals appoints new chairman and two directors - January 29, 2010
Afferent Pharmaceuticals names Bruce G. McCarthy as CEO - January 26, 2010
Rib-X Pharmaceuticals appoints Peter Greenleaf to board - January 20, 2010
China Aoxing Pharmaceutical: Hui Shao new CFO - January 20, 2010
Viamet Pharmaceuticals: William Moore chief scientific officer - January 11, 2010
Noven Pharmaceuticals announces executive appointments - January 5, 2010
BioCryst Pharmaceuticals elects Charles A. Sanders to the board - December 9, 2009
Jazz Pharmaceuticals: Kathryn Falberg chief financial officer - December 4, 2009
APP Pharmaceuticals: CEO Thomas H. Silberg to retire, John Ducker successor - December 3, 2009
Alexion Pharmaceuticals appoints William R. Keller to the board - December 2, 2009
Molecular Insight Pharmaceuticals announces changes to the board - November 25, 2009
Trubion Pharmaceuticals announces transition in leadership - November 17, 2009
RXi Pharmaceuticals appoints Noah D. Beerman as president and CEO - November 6, 2009
Calando Pharmaceuticals expands board of directors - November 4, 2009
Watson Pharmaceuticals: R. Todd Joyce SVP and CFO - October 30, 2009
Jiangbo Pharmaceuticals: COO Haibo Xu - October 22, 2009
WEX Pharmaceuticals appoints two new directors - October 22, 2009
NGM Biopharmaceuticals appoints Arthur D. Levinson to its board of directors - October 21, 2009
AcelRx Pharmaceuticals: Nigel Ray new vice president - October 14, 2009
Transdel Pharmaceuticals appoints Joachim P.H. Schupp as chief medical officer - October 13, 2009
Synergy Pharmaceuticals: Alan F. Joslyn new director - October 8, 2009
Raptor Pharmaceutical expands board of directors - October 1, 2009
Tianyin Pharmaceutical appoints Tao Yang as CFO - September 28, 2009
Caraco Pharmaceutical Laboratories: Georges Ugeux resigned - September 24, 2009
Elite Pharmaceuticals appoints CEO and chief scientific officer - September 22, 2009
Merrimack Pharmaceuticals: Clet Niyikiza senior vice president, development - September 21, 2009
Rib-X Pharmaceuticals appoints Tony Zook to board of directors - September 16, 2009
Caraco Pharmaceutical Laboratories appoints F. Folsom Bell to board - September 15, 2009
Myriad Pharmaceuticals elects Timothy R. Franson to board - September 15, 2009
Ritter Pharmaceuticals: Howard Foyt new EVP and CMO - September 11, 2009
EnVivo Pharmaceuticals: Stephen DiPalma is new chief financial officer - September 9, 2009
Constellation Pharmaceuticals appoints Edward E. Harlow as CSO - September 9, 2009
Rib-X Pharmaceuticals appoints Tom Kassberg chief business officer - September 4, 2009
Steven Holtzman joins Satori Pharmaceuticals board - September 3, 2009
Amylin Pharmaceuticals elects Paulo F. Costa chairman of the board - August 24, 2009
Pro-Pharmaceuticals appoints new member to the board - August 24, 2009
RXi Pharmaceuticals: CFO Stephen J. DiPalma to resign - August 21, 2009
Endo Pharmaceuticals: CEO Nancy J. Wysenski - August 12, 2009
Cempra Pharmaceuticals appointed John H. Johnson to board of directors - August 12, 2009
Molecular Insight Pharmaceuticals: Charles H. Abdalian, Jr. vice president of finance, CFO - August 5, 2009
NovaBay Pharmaceuticals: Roy J. Wu new senior vice president - August 3, 2009
SciClone Pharmaceuticals appoints Jon S. Saxe as chairman of board - July 31, 2009
Caraco Pharmaceutical Laboratories: Jitendra N. Doshi interim CEO - July 29, 2009
Sunesis Pharmaceuticals appoints Helen S. Kim to board of directors - July 27, 2009
Solace Pharmaceuticals appoints David Julius to Scientific Advisory Board - July 27, 2009
ChemGenex Pharmaceuticals: Thomas DeZao SVP and chief commercial officer - July 20, 2009
Pro-Pharmaceuticals names Gilbert S. Omenn to Scientific Advisory Board - July 14, 2009
NPS Pharmaceuticals appoints Colin Broom to the board - July 13, 2009
Dicerna Pharmaceuticals appointed David Madden as chairman of the board - July 9, 2009
OncoMed Pharmaceuticals: Sunil Patel senior vice president - July 7, 2009
Rib-X Pharmaceuticals appoints Russell Greig to board of directors - June 30, 2009
Cadence Pharmaceuticals: Scott Byrd chief commercial officer - June 22, 2009
Synta Pharmaceuticals: Vojo Vukovic senior VP and chief medical officer - June 20, 2009
Hollis-Eden Pharmaceuticals: James M. Frincke president and CEO - June 15, 2009
Lexicon Pharmaceuticals: Ajay Bansal executive vice president and CFO - June 2, 2009
Agios Pharmaceuticals: David Schenkein CEO, Duncan Higgons COO - May 27, 2009
Endo Pharmaceuticals appoints Alan G. Levin as CFO - May 8, 2009
Keryx Biopharmaceuticals: Michael P. Tarnok interim chairman and CEO - April 24, 2009
DFB Pharmaceuticals promoted Maxwell Lea to Vice President - April 23, 2009
Halo Pharmaceutical: George Bobotas chief scientific officer - April 20, 2009
Tigris Pharmaceuticals: Pedro Granadillo chairman of Board of Directors - April 16, 2009
Infinity Pharmaceuticals promoted Keilty and McPherson - April 10, 2009
NovaBay Pharmaceuticals: John A. Soderquist at Scientific Advisory Board - April 7, 2009
Valeant Pharmaceuticals appoints Steve Stefano of GSK to the Board of Directors - March 31, 2009
Hollis-Eden Pharmaceuticals dismisses CEO and founder - March 24, 2009
Bhaskar Chaudhuri President, Valeant Pharmaceuticals International - March 21, 2009
Bhaskar Chaudhuri President of Valeant Pharmaceuticals International - March 19, 2009
Barr Pharmaceuticals Shuffles Managers - March 28, 2008
Conatus Pharmaceuticals Appoints Anthony W. Fox as Chief Medical Officer - March 25, 2008